A single-arm confirmatory study of definitive chemoradiotherapy (dCRT) including salvage treatment in patients (pts) with clinical (c) stage II/III esophageal carcinoma (EC) (JCOG0909). This is an ...
Efficacy, tolerability, and biologic activity of a novel regimen of tremelimumab (T) in combination with durvalumab (D) for patients (pts) with advanced hepatocellular carcinoma (aHCC). This is an ...
With one of the highest rates of new cases and deaths of all cancers globally, there are numerous unmet needs for esophageal cancer treatment and clinical decision-making. "The overarching message is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results